bibliographic entry 10751038 [be/10751038]
https://w3id.org/oc/corpus/be/10751038

is a

• bibliographic reference

content

• Taal, W, Oosterkamp, HM, Walenkamp, AM, Dubbink, HJ, Beerepoot, LV, Hanse, MC, Buter, J, Honkoop, AH, Boerman, D, de Vos, FY, Dinjens, WN, Enting, RH, Taphoorn, MJ. Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (belob trial): A randomised controlled phase 2 trial, Lancet Oncol, 2014, 15, 943, 953, PMID: 25035291

references

• https://w3id.org/oc/corpus/br/435665